UnitedHealth Group (UNH)
(Delayed Data from NYSE)
$495.37 USD
+13.72 (2.85%)
Updated May 31, 2024 04:00 PM ET
After-Market: $496.33 +0.96 (0.19%) 7:58 PM ET
4-Sell of 5 4
B Value A Growth C Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$495.37 USD
+13.72 (2.85%)
Updated May 31, 2024 04:00 PM ET
After-Market: $496.33 +0.96 (0.19%) 7:58 PM ET
4-Sell of 5 4
B Value A Growth C Momentum A VGM
Zacks News
UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
UnitedHealth Group Incorporated (UNH) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
UnitedHealth (UNH) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
UnitedHealth Beats on Q3 Earnings, Raises View: ETFs to Gain
by Sweta Killa
UnitedHealth (UNH) reported better-than-expected third-quarter 2023 results. Earnings and revenues breezed past the Zacks Consensus Estimate. The company also lifted the lower end of its full-year earnings guidance.
Company News for Oct 16, 2023
by Zacks Equity Research
Companies In The Article Are: JPM, UNH, WFC, PGR.
UnitedHealth Group (UNH) Q3 Earnings Beat, Boosts '23 EPS View
by Zacks Equity Research
UnitedHealth Group's (UNH) management presently forecasts adjusted net EPS between $24.85 and $25.00 for 2023.
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Compared to Estimates, UnitedHealth (UNH) Q3 Earnings: A Look at Key Metrics
by Zacks Equity Research
The headline numbers for UnitedHealth (UNH) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
UnitedHealth Group (UNH) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
UnitedHealth (UNH) delivered earnings and revenue surprises of 3.63% and 1.02%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Dow ETF in Focus Ahead of Q3 Earnings
by Sweta Killa
With some of the blue-chip companies having reasonable chances of coming up with an earnings surprise, investors should closely monitor the movement of the Dow ETF and grab any opportunity that arises from a surge in any of the 30 stocks.
Is a Surprise Coming for UnitedHealth (UNH) This Earnings Season?
by Zacks Equity Research
UnitedHealth (UNH) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
The Zacks Analyst Blog UnitedHealth, Chevron, AstraZeneca, Adobe and Pfizer
by Zacks Equity Research
UnitedHealth, Chevron, AstraZeneca, Adobe and Pfizer are part of the Zacks Analyst Blog.
3 Stocks to Buy for Strong Dividend Growth
by Derek Lewis
Consistent dividend hikes reflect a company's successful nature, opting to share profits with shareholders. And that's precisely what these three companies have done.
Top Analyst Reports for UnitedHealth, Chevron & AstraZeneca
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth Group Incorporated (UNH), Chevron Corporation (CVX) and AstraZeneca PLC (AZN).
Will UnitedHealth (UNH) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
UnitedHealth (UNH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will UnitedHealth's (UNH) UnitedHealthcare Unit Aid Q3 Earnings?
by Zacks Equity Research
UnitedHealth's (UNH) third-quarter results are expected to benefit from an increase in UnitedHealthcare's Community & State revenues as well as the number of people it served.
Can High Medical Costs Affect UnitedHealth (UNH) Q3 Earnings?
by Zacks Equity Research
UnitedHealth's (UNH) third-quarter results are likely to reflect growth in memberships and premium levels.
Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)?
by Zacks Equity Research
Sector ETF report for FHLC
3 Companies to Buy for Robust Cash Flows
by Derek Lewis
Companies boasting strong cash-generating abilities can be great investments, as they have plenty of cash to fuel growth, pay out dividends, and easily wipe out debt.
UnitedHealth Group (UNH) Advances But Underperforms Market: Key Facts
by Zacks Equity Research
In the latest trading session, UnitedHealth Group (UNH) closed at $526.51, marking a +0.32% move from the previous day.
Soaring Tensions in Middle East Lead Investors Seeking Protection in Treasuries
by Mayur Thaker
And a September jobs report that looked impressive, but the devil's in the details.
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Beat the Market the Zacks Way: UnitedHealth, Novo Nordisk, Check Point Software in Focus
by Santanu Roy
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
Zacks Investment Ideas feature highlights: PepsiCo, Delta Air Lines and UnitedHealth Group
by Zacks Equity Research
PepsiCo, Delta Air Lines and UnitedHealth Group are part of the Zacks Investment Ideas article.
3 Key Quarterly Releases to Watch Next Week
by Derek Lewis
The Q3 cycle will undoubtedly be a critical period, particularly as the market tries to extend impressive year-to-date gains. Are there any surprises lurking?
Here's Why You Should Hold UnitedHealth Group (UNH) Stock Now
by Zacks Equity Research
Growing Membership, expanding government business, strategic acquisitions, improving operating margin and solid 2024 plans poise UnitedHealth Group (UNH) well for growth.